Company intelligence / Profile preview

湖南派格兰药业

Yueyang, Hunan, China

Ownership: Private
Employees: ~107
Development stage: Other

Overview

Hunan Paigelan Pharmaceutical Co., Ltd., founded in September 2022, is a wholly-owned subsidiary of King-eagle Med Technology Co., Ltd. Located in the Yueyang High-tech Industrial Park, the company serves as a specialized CMO/CDMO and industrialization platform for complex formulations, particularly focusing on transdermal drug delivery systems (TDDS) and topical formulations. Its advanced production lines are designed for gel patches, hot-melt patches, transdermal patches, semi-solid preparations, and sprays. In addition to its contract manufacturing capabilities, the company develops its own pipeline of complex generic and improved formulations, including a Rotigotine transdermal patch currently under NDA review and an Estradiol/Levonorgestrel patch in clinical development.

Therapeutic areas: Women's HealthNeurology
Modalities: Small molecule
Industry: Biotech

Partnerships

Lohmann Therapie-Systeme AG

Beyond the preview

Go deeper on 湖南派格兰药业.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 湖南派格兰药业.

Explore the full profile